IPAD-DB ID | C00718 |
Name | β-Santalol |
Category | Natural compounds |
2D Structure |
|
3D Structure | |
Molecular Formula | C 1 5 H 2 4 O |
Molecular Weight | 220.35 g/mol |
IUPAC Name | (Z)-2-methyl-5-[(1S, 2R, 4R)-2-methyl-3-methylidene-2-bicyclo[2.2.1]heptanyl]pent-2-en-1-ol |
InChI | InChI=1S/C15H24O/c1-11(10-16)5-4-8-15(3)12(2)13-6-7-14(15)9-13/h5, 13-14, 16H, 2, 4, 6-10H2, 1, 3H3/b11-5-/t13-, 14+, 15+/m1/s1 |
InChIKey | OJYKYCDSGQGTRJ-GQYWAMEOSA-N |
Canonical SMILES | CC(=CCCC1(C2CCC(C2)C1=C)C)CO |
PubChem CID | 6857681 |
DrugBank Accession Number | - |
CAS Registry Number | 77-42-9 |
Molecular Weight(Computed by SwissADME) | 220.35 |
Hac(Computed by SwissADME) | 16 |
Volume(Computed by ADMETlab 2.0) | 254.401 |
Density(Computed by ADMETlab 2.0) | 0.865 |
nRing(Computed by ADMETlab 2.0) | 2 |
MaxRing(Computed by ADMETlab 2.0) | 6 |
nHet(Computed by ADMETlab 2.0) | 1 |
fChar(Computed by ADMETlab 2.0) | 0 |
nRig(Computed by ADMETlab 2.0) | 10 |
Flexibility(Computed by ADMETlab 2.0) | 0.4 |
Stero Centers(Computed by ADMETlab 2.0) | 3 |
LogS(Computed by ADMETlab 2.0) | -4.273 |
LogD(Computed by ADMETlab 2.0) | 3.391 |
logP(Computed by ADMETlab 2.0) | 3.718 |
TPSA(Computed by SwissADME) | 20.23 |
Hbond Acceptor(Computed by SwissADME) | 1 |
Hbond Donor(Computed by SwissADME) | 1 |
Rotatable Bonds(Computed by SwissADME) |
GI Absorption(Computed by SwissADME) | High |
BBB(blood-brain barrier) Permeant(Computed by SwissADME) | Yes |
P-gp Substrate(Computed by SwissADME) | No |
CYP1A2 Inhibitor(Computed by SwissADME) | No |
CYP2C19 Inhibitor(Computed by SwissADME) | Yes |
CYP2C9 Inhibitor(Computed by SwissADME) | Yes |
CYP2D6 Inhibitor(Computed by SwissADME) | No |
CYP3A4 Inhibitor(Computed by SwissADME) | No |
log Kp(Skin Permeation)(Computed by SwissADME) | -4.14 |
Lipinski(Computed by SwissADME) | 0 |
Ghose(Computed by SwissADME) | 0 |
Veber(Computed by SwissADME) | 0 |
Egan(Computed by SwissADME) | 0 |
Muegge(Computed by SwissADME) | 1 |
Bioavailability Score(Computed by SwissADME) | 0.55 |